Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for CERTOLIZUMAB PEGOL
- Ixekizumab for the Management of Refractory Non-Infectious Uveitis: A Proof-of-Concept Study
- A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis
- Certolizumab in Recurrent Implantation Failure (RIF)
- The Effect of Cilostazol on Rheumatoid Arthritis Patients
- Stand UP to Rheumatoid Arthritis (SUPRA)
- COVID-19 VaccinE Response in Rheumatology Patients
- The Effectiveness and Safety of Camrelizumab/Lenvatinib Combined With TACE in Patients With Borderline Resectable HCC
- A Study of Chemotherapy and Certolizumab in People Who Have Lung Cancer That Can Be Treated With Surgery
- A Study to Assess the Pharmacokinetics of Certolizumab Pegol in Adults With Active Rheumatoid Arthritis
- A Study to Test Efficacy, Safety, and Pharmacokinetics of Certolizumab Pegol in Children and Adolescents With Moderately to Severely Active Crohn's Disease
- Treatment of Pregnancy RA
- A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol)
- A Study to Evaluate the Efficacy, Safety, and Drug Concentration of Certolizumab Pegol (CZP) in Children and Adolescent Study Participants With Moderate to Severe Chronic Plaque Psoriasis (PSO)
- Zr-89 Cimzia PET Imaging Rheumatoid Arthritis
- Rotation or Change of Biotherapy After TNF Blocker Treatment Failure for Axial Spondyloarthritis
- Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
- Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately t
- Autologous Stem Cell Transplant for Crohn's Disease
- A Study to Test the Efficacy and Safety of Bimekizumab and Certolizumab Pegol in Patients With Active Ankylosing Spondylitis
- IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
- A Study to Test the Efficacy and Safety of Certolizumab Pegol in Japanese Subjects With Moderate to Severe Chronic Psoriasis
- A Study to Assess the Effects of Certolizumab Pegol on the Reduction of Anterior Uveitis (AU) Flares in Axial Spondyloarthritis Subjects With a Documented History of AU
- Efficacy of CROWN in Repair and Maintenance of the Intestinal Mucosa in Patients With CD Receiving Anti-TNF Therapy
- Lipids, Inflammation, and CV Risk in RA
- Entyvio (Vedolizumab) Long Term Safety Study
- Does Clinical Response Correlate With Serum Certolizumab Levels?
- Pilot Study Evaluating the Efficacy of Certolizumab Pegol for Interstitial Cystitis
- Dose Reduction for Early Rheumatoid Arthritis Patients With Low Disease Activity
- An Open-label Extension Study of Certolizumab Pegol in Chinese Patients With Rheumatoid Arthritis Who Enrolled in RA0044
- RICE: Remission by Intra-articular Injection Plus CErtolizumab
- Anti-TNFα Use During Elective Foot and Ankle Surgery in Patients With Rheumatoid Arthritis
- A Study of Certolizumab Pegol as Additional Therapy in Chinese Patients With Active Rheumatoid Arthritis
- Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
- Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas
- Prediction of Response to Certolizumab Pegol Treatment by Functional MRI of the Brain
- Corticosteroids and Anti TNF in Methotrexate Inadequate Responder Rheumatoid Arthritis Patient
- Cimzia Versus Mesalamine for Crohn's Recurrence
- Scintigraphic Detection of the Biodistribution of Tumor Necrosis Factor With a Radiolabeled Anti-TNFα in Patients With Active Rheumatoid Arthritis and Active Axial and Peripheral Spondyloarthritis
- EUS Evaluation of Perianal and Peri-rectal Fistulizing Crohn's Disease With CERTOLIZUMAB Treatment
- Pediatric Arthritis Study of Certolizumab Pegol
- Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate
- Active Conventional Therapy Compared to Three Different Biologic Treatments in Early Rheumatoid Arthritis With Subsequent Dose Reduction
- Efficacy Confirmation Study of CDP870 in Early Rheumatoid Arthritis
- Rheumatoid Arthritis Treatment and Biopsy Study Assessing Certolizumab Pegol (Cimzia)
- A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)
- The Effect of Certolizumab Pegol on MRI Synovitis and Bone Edema in Rheumatoid Arthritis Patients
- Open-label, Extension Study of CDP870 in Patients With Rheumatoid Arthritis
- Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol
- Can TNF-Alpha Incomplete Secondary Responders Attain a Safe and Efficacious Response Switching to Cimzia
- Certolizumab and Lower Extremity Lymph Flow in Rheumatoid Arthritis (RA)
- Study of Cimzia for the Treatment of Ulcerative Colitis
- Assessment of Small Bowel Healing in Crohn's Disease Patients Treated With Cimzia Using Wireless Capsule Endoscopy
- A Study of CDP870 as Add-on Meditation to Methotrexate (MTX) in Patients With Rheumatoid Arthritis
- The Use of Certolizumab Pegol for Treatment of Active Crohn's Disease in Children and Adolescents
- Long-term Treatment Study of Certolizumab Pegol (CDP870) as Add-on Medication to Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients
- Long-term Treatment Study of Certolizumab Pegol Without Coadministration of Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients
- Comparison Bioequivalence Study: Pre-filled Syringe (Reference) Versus Auto-injection Device (Test)
- SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry
- Open Label Extension for Patients Coming From the Dosing Flexibility Study in Patients With Rheumatoid Arthritis (RA)
- Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis
- Dosing Flexibility Study in Patients With Rheumatoid Arthritis
- A Trial Evaluating Safety of Chronic Therapy With Certolizumab Pegol in Crohn's Disease
- Evaluate Efficacy of Certolizumab in Crohn's Patients With Draining Fistulas
- Efficacy of Re-treatment With Cimzia® in Subject With Chronic Plaque Psoriasis
- A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis
- A Placebo Controlled Study to Assess Efficacy and Safety of Certolizumab Pegol in the Treatment of Rheumatoid Arthritis
Clinical trials list
click for details